“The study is expected to be a quick one, with d
Post# of 72440
(Total Views: 374)
Posted On: 02/10/2020 8:50:21 PM
“The study is expected to be a quick one, with dosing completed within several weeks of commencement, and, if successful, would translate into numerous potential positive outcomes for the company,” noted Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals.
IMO Sounds like someone is waiting in the wings...
IMO Sounds like someone is waiting in the wings...
(6)
(1)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Leo Took The Money and Ran
Scroll down for more posts ▼